A New MHC Class I & II Deficient Platform Humanized With PBMC Has Delayed Xenogeneic GvHD

In Vivo Evaluation Of Bispecific T-Cell Engager Efficacy & Safety

$0.47 - $7.00

Select Options

Lupus Efficacy Studies

$0.47 - $7.00

Select Options

Targeting Natural Killer Cell Activity With Humanized NSG IL15 Mouse Model

$0.34 - $3.00

Select Options

MS-EAE Efficacy Studies

$0.47 - $7.00

Select Options

In Vivo Evaluation Of Bispecific T-Cell Engager Efficacy & Safety

$0.47 - $7.00

Select Options

Humanized Mouse Models

$0.34 - $3.00

Select Options

In Vivo Safety and Efficacy Platform for Immunotherapies

$0.47 - $7.00

Select Options

Type 1 Diabetes Efficacy Studies

$0.47 - $7.00

Select Options